Agilon Health Inc (AGL)
4.32 x 7 4.50 x 5
Post-market by (Cboe BZX)
4.48 unch (unch) 03/25/25 [NYSE]
4.32 x 7 4.50 x 5
Post-market 4.50 +0.02 (+0.45%) 17:36 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2019 | 12-2017 | 12-2006 | |
Sales | 794,411 | 0 | 0 |
Cost of Goods | 765,900 | N/A | N/A |
Gross Profit | 28,511 | N/A | N/A |
Operating Expenses | 135,985 | 0 | 0 |
Operating Income | -106,574 | N/A | N/A |
Interest Expense | 9,068 | 0 | 0 |
Other Income | 955 | 0 | 0 |
Pre-tax Income | -114,687 | 0 | 0 |
Income Tax | -232 | N/A | N/A |
Net Income Continuous | -114,455 | N/A | N/A |
Net Income Discontinuous | -168,285 | N/A | N/A |
Minority Interests | -152 | N/A | N/A |
Net Income | $-282,588 | $N/A | $N/A |
EPS Basic Total Ops | -0.96 | N/A | N/A |
EPS Basic Continuous Ops | -0.39 | N/A | N/A |
EPS Basic Discontinuous Ops | -0.57 | N/A | N/A |
EPS Diluted Total Ops | -0.96 | N/A | N/A |
EPS Diluted Continuous Ops | -0.39 | N/A | N/A |
EPS Diluted Discontinuous Ops | -0.57 | N/A | N/A |
EPS Diluted Before Non-Recurring Items | N/A | N/A | 2.72 |
EBITDA(a) | $-65,161 | $N/A | $N/A |